Psychosis genes? Next generation genetics in clinical psychiatry. Anna C Need Imperial College London
|
|
- Alexandra Marsh
- 6 years ago
- Views:
Transcription
1 Psychosis genes? Next generation genetics in clinical psychiatry Anna C Need Imperial College London
2 Overview Are there genetic variants that cause* psychosis? Can we test for them in the clinic? Can we use this information to help treat patients?
3 How could a genetic diagnosis be used to help patients? Could identify a treatable (curable) illness! Can help guide drug choice seizure threshold obesity Genetic testing and monitoring of family members Specific educational support recommendations Applications for educational support Help understand why guil prevent dangerous alternative treatments
4 Patient Power Patients (or their parents) with a specific genetic diagnosis can connect through social media Get better prognosis Support each other emotionally Share treatment experiences Discuss symptoms Provide insight that clinicians with limited exposure to very small numbers of cases cannot
5 Mendelian vs. Complex Autosomal dominant Autosomal Recessive X-linked Recessive X-linked domainant Mitochondrial Multiple genetic contributors Strong environmental effects Gene-gene interactions Gene-environmental interactions
6 Mendelian Forms of Complex Brain Disorders Alzheimer s: PSEN1, PSEN2, APP. Parkinsons: SNCA, Parkin, PINK1... Epilepsy: LGI1, CHRNA4, KCNQ3...
7 Mendelian Forms of Schizophrenia? (no) 1. CNVs and psychosis 2. Genes and psychosis 3. Mendelian disorders that cause psychosis 4. The 100,000 genomes project 5. Our diagnostic sequencing pilot
8 Copy Number Variants (CNVs) (Thanks to the Autism Reading Room, the Figure)
9 22q11: Velo-cardio-facial syndrome hypoparathyroidism Underdeveloped thymus or absent thymus, which results in problems in the immune system heart defects cleft lip and/or palate Approx 1/3 VCFS patients develop schizophrenia Approximately 1% of patients with schizophrenia have 22qDS. The schizophrenia in 22qDS is indistinguishable by symptoms, treatment response, neurocognitive profile, or MRI brain anomalies.
10 Similarly Grayton et al., 2012 doi: /j.pneurobio
11 CNVs Clinical genetics services screen entire genome (all chromosomes at once) and report back pathogenic variants Could be genetically diagnosing several percent of schizophrenia cases already with clinical genetic analysis
12 1. CNVs and psychosis 2. Genes and psychosis 3. Mendelian disorders that cause psychosis 4. The 100,000 genomes project 5. Our diagnostic sequencing pilot
13 SETD1A (Singh et al., Nature Neuroscience, March 2016)
14
15
16 1. CNVs and psychosis 2. Genes and psychosis 3. Mendelian disorders that cause psychosis 4. The 100,000 genomes project 5. Our diagnostic sequencing pilot
17 Mendelian Genetic Disorders and Psychosis No Mendelian schizophrenias Many disorders can present with psychosis as part of their symptoms
18 Mendelian disorders that can manifest with psychosis* Disorder Gene Symbol Disorder ADRENOLEUKODYSTROPHY; ALD ABCD1 USHER SYNDROME, TYPE I; USH1 MYO7A ACYL-CoA DEHYDROGENASE,SHORT-CHAIN, DEFICIENCY OF; ACADSD ACADS NORRIE DISEASE; ND NDP SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD ALDH5A1 NEUROFIBROMATOSIS, TYPE I; NF1 NF1 METACHROMATIC LEUKODYSTROPHY ARSA CEREBRAL ARTERIOPATHYWITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY NOTCH3 ARGININOSUCCINIC ACIDURIA ASL NIEMANN-PICK DISEASE, TYPE C1; NPC1 NPC1 DYSTONIA 12; DYT12 ATP1A3 NIEMANN-PICK DISEASE, TYPE C2; NPC2 NPC2 DARIER-WHITE DISEASE; DAR ATP2A2 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO OTC WILSON DISEASE ATP7B PHENYLKETONURIA; PKU PAH MACHADO-JOSEPH DISEASE; MJD ATXN3 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1 PANK2 MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7 C10orf2 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9 PCDH19 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS C9orf72 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2 PDE11A MIGRAINE, FAMILIAL HEMIPLEGIC,WITH CEREBELLAR ATAXIA CACNA1A BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5 PDGFB HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY CBS SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO POLG CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3 CLN3 PORPHYRIA VARIEGATA PPOX CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A CLN6 SPINOCEREBELLAR ATAXIA 12; SCA12 PPP2R2B COPROPORPHYRIA, HEREDITARY; HCP CPOX PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1 PRKAR1A CEREBROTENDINOUS XANTHOMATOSIS; CTX CYP27A1 HUNTINGTON DISEASE-LIKE 1; HDL1 PRNP WOODHOUSE-SAKATI SYNDROME DCAF17 PRION DISEASE PRNP PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE, EARLY-ONSET; PARK7 DJ1 / PARK7 ALZHEIMER DISEASE 3 PSEN1 CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B DNAJC5 ALZHEIMER DISEASE 4 PSEN2 CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN DNMT1 COFFIN-LOWRY SYNDROME;CLS RPS6KA3 LIPOID PROTEINOSIS OF URBACH AND WIETHE ECM1 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN SLC12A6 KLEEFSTRA SYNDROME EHMT1 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1 SLC20A2 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED GRN CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2 SLC25A13 USHER SYNDROME, TYPE IIIB; USH3B HARS HARTNUP DISORDER SLC6A19 NARCOLEPSY 1; NRCLP1 HCRT CEREBRAL CREATINE DEFICIENCY SYNDROME 1 SLC6A8 TAY-SACHS DISEASE; TSD HEXA LYSINURIC PROTEIN INTOLERANCE; LPI SLC7A7 SANDHOFF DISEASE HEXB PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1/ PARKINSON DISEAE 4 SNCA ACUTE PORPHYRIA INTERMITTENT HMBS SPINOCEREBELLAR ATAXIA 17; SCA17 TBP MENTAL RETARDATION, X-LINKED,SYNDROMIC 10; MRXS10 HSD17B10 VELOCARDIOFACIAL SYNDROME TBX1 HUNTINGTON DISEASE; HD HTT THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH THRB HURLER-SCHEIE SYNDROME IDUA MOHR-TRANEBJAERG SYNDROME; MTS TIMM8A CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2 ITM2B TUBEROUS SCLEROSIS 1; TSC1 TSC1 EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5 KCNT1 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2 TTC19 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1 LGI1 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED TTR LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL MECP2 CHOREOACANTHOCYTOSIS; CHAC VPS13A MENTAL RETARDATION, X-LINKED, SYNDROME 13; MRXS13 MECP2 WOLFRAM SYNDROME 1; WFS1 WFS1 LUJAN-FRYNS SYNDROME MED12 WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL WFS1 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblc TYPE MMACHC MCLEOD SYNDROME; MCLDS XK SPASTIC PARAPLEGIA 15,AUTOSOMAL RECESSIVE;SPG15 *Searched OMIM phenotype descriptions for psycho*, hallucinations, delusions, parano*, mania and psychiatric and curated using clinical reports in PubMed. Gene Symbol ZFYVE26
19 Mendelian disorders that can manifest with psychosis* Darier-White Disease (OMIM): Darier-White disease, also known as keratosis follicularis, is an autosomal dominant skin disorder characterized by warty papules and plaques in seborrheic areas (central trunk, flexures, scalp, and forehead), palmoplantar pits, and distinctive nail abnormalities (Sakuntabhai et al., 1999). mental illnesses, such as psychosis and affective disorder, have been reported in association with Darier disease. Disorder Gene Symbol Disorder ADRENOLEUKODYSTROPHY; ALD ABCD1 USHER SYNDROME, TYPE I; USH1 MYO7A ACYL-CoA DEHYDROGENASE,SHORT-CHAIN, DEFICIENCY OF; ACADSD ACADS NORRIE DISEASE; ND NDP SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD ALDH5A1 NEUROFIBROMATOSIS, TYPE I; NF1 NF1 METACHROMATIC LEUKODYSTROPHY ARSA CEREBRAL ARTERIOPATHYWITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY NOTCH3 ARGININOSUCCINIC ACIDURIA ASL NIEMANN-PICK DISEASE, TYPE C1; NPC1 NPC1 DYSTONIA 12; DYT12 ATP1A3 NIEMANN-PICK DISEASE, TYPE C2; NPC2 NPC2 DARIER-WHITE DISEASE; DAR ATP2A2 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO OTC WILSON DISEASE ATP7B PHENYLKETONURIA; PKU PAH MACHADO-JOSEPH DISEASE; MJD ATXN3 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1 PANK2 MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7 C10orf2 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9 PCDH19 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS C9orf72 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2 PDE11A MIGRAINE, FAMILIAL HEMIPLEGIC,WITH CEREBELLAR ATAXIA CACNA1A BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5 PDGFB HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY CBS SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO POLG Wolfram syndrome(omim): Wolfram syndrome-1 is a rare and severe autosomal recessive neurodegenerative disease characterized by diabetes mellitus, optic atrophy, diabetes insipidus, and deafness (DIDMOAD). Additional clinical features may include renal abnormalities, ataxia, dementia or mental retardation, and diverse psychiatric illnesses. CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3 CLN3 PORPHYRIA VARIEGATA PPOX CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A CLN6 SPINOCEREBELLAR ATAXIA 12; SCA12 PPP2R2B COPROPORPHYRIA, HEREDITARY; HCP CPOX PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1 PRKAR1A CEREBROTENDINOUS XANTHOMATOSIS; CTX CYP27A1 HUNTINGTON DISEASE-LIKE 1; HDL1 PRNP WOODHOUSE-SAKATI SYNDROME DCAF17 PRION DISEASE PRNP PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE, EARLY-ONSET; PARK7 DJ1 / PARK7 ALZHEIMER DISEASE 3 PSEN1 CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B DNAJC5 ALZHEIMER DISEASE 4 PSEN2 CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN DNMT1 COFFIN-LOWRY SYNDROME;CLS RPS6KA3 LIPOID PROTEINOSIS OF URBACH AND WIETHE ECM1 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN SLC12A6 KLEEFSTRA SYNDROME EHMT1 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1 SLC20A2 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED GRN CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2 SLC25A13 USHER SYNDROME, TYPE IIIB; USH3B HARS HARTNUP DISORDER SLC6A19 Acute intermittent porphyria(omim): Acute episodes of a variety of gastrointestinal and neuropathic symptoms; between episodes, the patient is healthy. Abdominal pain is the most common symptom, sometimes with constipation and urinary retention; paraesthesias and paralysis also occur, and death may result from respiratory paralysis. Many other phenomena, including seizures, psychotic episodes, and hypertension, may occur in acute attacks NARCOLEPSY 1; NRCLP1 HCRT CEREBRAL CREATINE DEFICIENCY SYNDROME 1 SLC6A8 TAY-SACHS DISEASE; TSD HEXA LYSINURIC PROTEIN INTOLERANCE; LPI SLC7A7 SANDHOFF DISEASE HEXB PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1/ PARKINSON DISEAE 4 SNCA ACUTE PORPHYRIA INTERMITTENT HMBS SPINOCEREBELLAR ATAXIA 17; SCA17 TBP MENTAL RETARDATION, X-LINKED,SYNDROMIC 10; MRXS10 HSD17B10 VELOCARDIOFACIAL SYNDROME TBX1 HUNTINGTON DISEASE; HD HTT THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH THRB HURLER-SCHEIE SYNDROME IDUA MOHR-TRANEBJAERG SYNDROME; MTS TIMM8A CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2 ITM2B TUBEROUS SCLEROSIS 1; TSC1 TSC1 EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5 KCNT1 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2 TTC19 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1 LGI1 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED TTR LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL MECP2 CHOREOACANTHOCYTOSIS; CHAC VPS13A MENTAL RETARDATION, X-LINKED, SYNDROME 13; MRXS13 MECP2 WOLFRAM SYNDROME 1; WFS1 WFS1 LUJAN-FRYNS SYNDROME MED12 WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL WFS1 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblc TYPE MMACHC MCLEOD SYNDROME; MCLDS XK SPASTIC PARAPLEGIA 15,AUTOSOMAL RECESSIVE;SPG15 *Searched OMIM phenotype descriptions for psycho*, hallucinations, delusions, parano*, mania and psychiatric and curated using clinical reports in PubMed. Gene Symbol ZFYVE26
20 I would know if my patient had that! (Variable penetrance/ expressivity) Genome-first approach has shown that, like CNVs, Mendelian disorders much more variable than previously thought May present with subset of classic symptoms (or entirely new symptoms) Some may present with just psychosis!
21
22
23
24
25 Can we diagnose these now? No too many genes presentation too unpredictable Need to be able to look at all candidates at once genome/exome seq
26 1. CNVs and psychosis 2. Developmental disorders and psychosis 3. Mendelian disorders that cause psychosis 4. The 100,000 genomes project 5. Our diagnostic sequencing pilot
27 The 100,000 Genomes Project Funded by HEE to train NHS Staff to lead the integration of genomic technology into patient care within the NHS Coming soon.schizophrenia?
28 More genetic forms? Childhood onset psychosis Multiplex families Patients with comorbidities Treatment resistant schizophrenia
29 1. CNVs and psychosis 2. Developmental disorders and psychosis 3. Mendelian disorders that cause psychosis 4. The 100,000 genomes project 5. Our diagnostic sequencing pilot
30 Genetic Research into Childhood In collaboration with Onset Psychosis Primary Objective To determine if next generation sequencing can lead to clinically relevant genetic diagnosis in child psychiatry. Secondary Objective 1. To identify candidate genes that are relevant to the more common adult onset forms of the disorder. 2. To establish a database of patients with childhood onset psychosis and their family members that are willing to be contacted about other studies that will help us to understand the etiology, expression and course of childhood onset psychosis. Dr. Anthony James Recruiting patients diagnosed with psychotic illness before age 14 a.need@imperial.ac.uk
31 ACTIVELY RECRUITING! Aiming for 100, have 27 South London and Maudsley South West London and St George's Leeds & York Partnership Lincolnshire Partnership Northumberland, Tyne & Wear Mersey Care Bradford Oxford Health Cornwall Foundation Trust Central and North West London GOSH Whittington Hospital Barnet Enfield and Haringey Central Manchester University Hospitals Birmingham Childrens Hospital Lancashire Care Dorset Healthcare South West Yorkshire Partnership NHS Foundation Trust Tees, Esk and Wear Leicestershire Partnership Rotherham, Doncaster and South Humber Northamptonshire
32 Interesting? Sleep disorders Two have siblings who have undergone gender reassignment
33 Conclusions Are there genetic variants that cause psychosis? Yes, there are likely to be hundreds (at least) Can we test for them in the clinic? CNVs can be identified with existing genetics services Sequence variants soon Can we use this information to help treat patients? I ll tell you next year!
34 Acknowledgements Tony James Clare Borsay Mitra Ameri Amy Claringbold Claudia Adele Marinos Kyriakopoulos Kouser Shaik Joseph Horne Fiona Padgett Isabel Ellory Sarojit Ganguly Gillian Rose Jon Goldin Navin Chandra Biki Valle Jane Whittaker Ruth Marshall Alison Robinson Ashley liew Biradar Rajeev Catehrine O Callaghan Niloufar Mirhaghani Jose Mediavilla Abhay Rathore Nicoletta Gentili Debbie Marsden Richard Church Marie Curie Career Integration Grant; Elsie Widdowson Fellowship
35 Do you know of someone diagnosed with psychosis before age 14? - Please me: a.need@imperial.ac.uk - or Tony James: anthony.james@psych.ox.ac.uk It will be very minimum trouble to you!
FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease
Ophthalmologic Signs of Genetic Neurological Disease ES ROACH,MD. Ophthalmologic Signs of Genetic Neurological Disease Conjunctival lesions Corneal lesions Lesions of iris & lens Retinal vascular lesions
More informationWhole exome sequencing Gene package Neurodegeneration version 3,
Whole Exome Sequencing Gene package Neurodegeneration, version 3, 30 7 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on
More informationGenetic Testing for Neurologic Disorders
Genetic Testing for Neurologic Disorders MP9497 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre- and post-test genetic counseling
More information! slow, progressive, permanent loss of neurologic function.
UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation
More informationUKGTN Testing Criteria
Test name: Epilepsy 53 Gene Panel UKGTN Testing Criteria Approved name and symbol of disorder/condition(s): Epilepsy Panel Test See Appendix 1 Approved name and symbol of gene(s): See Appendix 2 OMIM number(s):
More informationAll diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationGENETICS AND TREATMENT OF DYSTONIA
GENETICS AND TREATMENT OF DYSTONIA Oksana Suchowersky, M.D., FRCPC, FCCMG Professor of Medicine, Medical Genetics, and Psychiatry Toupin Research Chair in Neurology DYSTONIA Definition: abnormal sustained
More informationClinical Genetics & Dementia
Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history
More informationForm D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationvariant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationThe Pathogenesis of Dystonia: Past, Present and Future
The Pathogenesis of Dystonia: Past, Present and Future NIH Grant Disclosures U54 TR001456, R21 NS096445, R56 NS102980 Private Foundation Disclosures Benign Essential Blepharospasm Research Foundation Cure
More informationSummary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism
Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to
More informationBROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationNatural History of JNCL and other NCLs
Natural History of JNCL and other NCLs Jonathan W. Mink, MD PhD Departments of Neurology, Neurobiology & Anatomy, Brain & Cognitive Sciences, and Pediatrics University of Rochester Neuronal Ceroid Lipofuscinosis
More informationFamilial dystonia with cerebral calcification
Familial dystonia with cerebral calcification case report and genetic update M. Signaevski, A.K. Wszolek, A.J. Stoessel, R. Rademakers, and I.R. Mackenzie Vancouver General Hospital, BC, Canada Mayo Clinic
More informationRiunione Regionale SIN Campania
Riunione Regionale SIN Campania Dott.ssa Maria Lieto Dipartimento di Neuroscienze, Università Federico II Napoli Salerno, 14 dicembre 2018 HEREDITARY ATAXIAS SCAs (35 genes) ARCAs (94 genes) Diagnosis?
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationStrand Neuromuscular Disorders Test: Genes & Test Selection
1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection
More informationContents. Introduction. Introduction 03
Genes and dementia Introduction This information is for anyone who wants to know more about the link between genes and dementia. This includes people living with dementia, their carers, friends and families.
More informationMovement disorders in childhood: assessment and diagnosis. Lucinda Carr
Movement disorders in childhood: assessment and diagnosis Lucinda Carr Movement disorders in childhood: Assessment Classification Causes Diagnosis Presentation of movement disorders in childhood: Concerns
More informationUpdate on the Genetics of Ataxia. Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic
Update on the Genetics of Ataxia Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic Outline Definitions Review of genetics Autosomal Dominant cerebellar ataxias Autosomal Recessive cerebellar
More informationREQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First
#: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST
More informationNeurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018
Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive
More informationChapter 18 Genetics of Behavior. Chapter 18 Human Heredity by Michael Cummings 2006 Brooks/Cole-Thomson Learning
Chapter 18 Genetics of Behavior Behavior Most human behaviors are polygenic and have significant environmental influences Methods used to study inheritance include Classical methods of linkage and pedigree
More informationCentral Nervous System
Central Nervous System Developmental delay Loss of milestones Intellectual disability Dementia Seizures Neuropsychiatric disturbances Cerebral palsy Migraines Stroke and stroke-like episodes Movement disorders:
More informationSELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)
DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL
More informationNew Advances in Psychiatric Genetics Joseph Shen, M.D., Ph.D. Aisha Furqan, LCGC Clinical Genetics UCSF-Fresno Community Regional Medical Center
New Advances in Psychiatric Genetics Joseph Shen, M.D., Ph.D. Aisha Furqan, LCGC Clinical Genetics UCSF-Fresno Community Regional Medical Center Background Genetic testing Treatment options: Pharmacogenetics
More informationP20.2. Characteristics of different types of dementia and challenges for the clinician
P20.2. Characteristics of different types of dementia and challenges for the clinician, professor Danish Dementia Research Center Rigshospitalet, University of Copenhagen (Denmark) This project has received
More informationPathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)
Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits
More informationPREDICAGEN LLC REPORT
The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because
More informationMNG Exome Sequencing Test Request Form
Whole Exome Sequencing MNG Exome Sequencing Test Request Form Note: Clinical Information and Consent Form are required for MNG Exome Orders. IMPORTANT: Please note if any additional samples will be shipped
More informationHuntington s Disease and HD-like Disorders Prof. Sarah Tabrizi MD PhD FMedSci
Huntington s Disease and HD-like Disorders UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery Queen Square London 1 Genetic causes of chorea: HD and HD-like disorders (HD phenocopies)
More informationReferring Physician Information Name: (Last, First, Middle):
Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background
More informationGenetic Diseases. SCPA202: Basic Pathology
Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities
More informationMNGenome Sequencing Test Request Form
MNGenome Sequencing Test Request Form Whole Whole Genome Exome Sequencing Note: Clinical Information and Consent Form are required for MNGenome Orders. *Please note if samples are shipping separately as
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationFRAMBU. Resource Centre for Rare Disorders
FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory
More informationQUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.
Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:
More informationC-type: For each numbered item or question, indicate whether it is associated
C-type: For each numbered item or question, indicate whether it is associated with: (A) A only (B) B only (C) Both A and B (D) Neither A nor B ( ) 1. About neuroleptic malignant syndrome and serotonin
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationSupplementary Note. Patient #1 Additional Details
Supplementary Note Patient #1 Additional Details Past medical history: The patient was ambidextrous. She had a history of hypertension, hyperlipidemia, migraines, and remote history of an ANA-positive
More informationPresentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
More informationpanel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders
NGS tests panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders UKGTN website lists 13 laboratories offering a total of 56 panel test UKGTN listed panel
More informationBALANCE 13 DISORDERS OF WATER DISORDERS CHARACTERISED BY POLYDIPSIA AND POLYURIA. (vasopressin deficiency) 1 [primary] [secondary 6C] insipidus
Wit JM, Ranke MB, Kelnar CJH (eds): ESPE classification of paediatric endocrine diagnosis. 13. Disorders of water balance. Horm Res 2007;68(suppl 2):96 97 ESPE Code Diagnosis OMIM ICD10 13 DISORDERS OF
More informationHEREDITARY ATAXIAS (HA)
HEREDITARY ATAXIAS (HA) Elison Sarapura-Castro January 11, 2018 OUTLINE Background Causes of ataxia and classification of HA SCAs Diagnostic workup Final Remarks BACKGROUND 25 years ago, ATAXIA: Abscense
More informationbrain MRI for neuropsychiatrists: what do you need to know
brain MRI for neuropsychiatrists: what do you need to know Christoforos Stoupis, MD, PhD Department of Radiology, Spital Maennedorf, Zurich & Inselspital, University of Bern, Switzerland c.stoupis@spitalmaennedorf.ch
More informationShake It Off: Recognizing & Treating Movement Disorders
Ooi Phaik Yee Annual scientific meeting College of Medicine, Academy of Medicine of Malaysia 12 th November 2017 Shake It Off: Recognizing & Treating Movement Disorders MOVEMENT DISORDER A group of symptoms
More informationOverview of Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders
Overview of Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders What is NBIA? Neurodegeneration with Brain Iron Accumulation is a group of inherited neurological disorders characterized by
More informationEpilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie
Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie dr. Hannah Stamberger prof. dr. Peter De Jonghe Neurogenetics group, DMG, VIB http://www.molgen.vib-ua.be Disclosures
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationBewegingsstoornisssen genpanel v1 (203 genen)
Bewegingsstoornisssen genpanel v1 (203 genen) ABCB7 99,8 Anemia, sideroblastic, with ataxia, 301310 ABCD1 98,7 Adrenoleukodystrophy, 300100 Adrenomyeloneuropathy, adult, 300100 ABHD12 93,8 Polyneuropathy,
More informationAn Introduction to mitochondrial disease.
9 th September 2017 An Introduction to mitochondrial disease. Dr Andy Schaefer Consultant Neurologist and Clinical Lead NHS Highly Specialised Rare Mitochondrial Disease Service and Wellcome Trust Centre
More informationTable of Contents. Preface... xi. Part I: Introduction to Movement Disorders
Table of Contents Visit www.healthreferenceseries.com to view A Contents Guide to the Health Reference Series, a listing of more than 14,000 topics and the volumes in which they are covered. Preface...
More informationForm A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abuse substance. See Substance abuse Acquired disorders presenting as psychosis in children and young adults, 581 608. See also specific
More informationClinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationMITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital
MITOCHONDRIAL DISEASE Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital Disclosures & Disclaimers United Mitochondrial Disease Foundation Research Grant North American Mitochondrial
More informationCLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands
CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE Bwee Tien Poll-The Amsterdam UMC The Netherlands FRAMEWORK OF PRINCIPALS 1. Problem-oriented clinical approach 2. Biomarkers in plasma, urine, CSF
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationLOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM
LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM Inderneel Sahai, MD, FACMG Newborn Screening and Genetic Testing Symposium Oct 2014
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationAcute Porphyria. Penelope Stein Haematological Medicine, King s College Hospital, London
Acute Porphyria Penelope Stein Haematological Medicine, King s College Hospital, London Why is acute porphyria important? Easy to miss - rare, non-specific presentation Severe attacks may be life-threatening
More informationDEVELOPMENT OF A NEW PATIENT REPORTED OUTCOME MEASURE FOR MENTAL HEALTH SERVICES
DEVELOPMENT OF A NEW PATIENT REPORTED OUTCOME MEASURE FOR MENTAL HEALTH SERVICES John Brazier Economic Evaluation Policy Research Unit School of Health and Related Research Contact: ReQoL@sheffield.ac.uk
More informationFatty Acids Synthesis L3
Fatty Acids Synthesis L3 The pathway for fatty acid synthesis occurs in the cytoplasm, whereas, oxidation occurs in the mitochondria. The other major difference is the use of nucleotide co-factors. Oxidation
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationExploring hereditary ataxia and spasticity in the era of whole exome sequencing
Universiteit Antwerpen Faculteit Geneeskunde en Gezondheidswetenschappen Exploring hereditary ataxia and spasticity in the era of whole exome sequencing Proefschrift voorgelegd tot het behalen van de graad
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More information23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function
1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency
More informationChapter 13. DiGeorge Syndrome
Chapter 13 DiGeorge Syndrome DiGeorge Syndrome is a primary immunodeficiency disease caused by abnormal migration and development of certain cells and tissues during fetal development. As part of the developmental
More informationNon-Genetic Ataxia Susan L. Perlman, M.D. Clinical Professor of Neurology David Geffen School of Medicine at UCLA Director, Ataxia Clinic
Non-Genetic Ataxia Susan L. Perlman, M.D. Clinical Professor of Neurology David Geffen School of Medicine at UCLA Director, Ataxia Clinic Is Anything Non-Genetic? 1,212,000 references in PubMed under genetics
More informationADULT-ONSET (INFRATENTORIAL) LEUKOENCEPHALOPATHY as PRESENTING MANIFESTATION of ERDHEIM-CHESTER DISEASE
ADULT-ONSET (INFRATENTORIAL) LEUKOENCEPHALOPATHY as PRESENTING MANIFESTATION of ERDHEIM-CHESTER SEASE GIULIO CAVALLI, M.D. INTERNAL MECINE AND CLINICAL IMMUNOLOGY IRCCS SAN RAFFAELE HOSPITAL VITA-SALUTE
More informationBiology 3201 Nervous System # 7: Nervous System Disorders
Biology 3201 Nervous System # 7: Nervous System Disorders Alzheimer's Disease first identified by German physician, Alois Alzheimer, in 1906 most common neurodegenerative disease two thirds of cases of
More informationObjectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit
Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features
More informationMolecular Imaging and the Brain
Molecular imaging technologies are playing an important role in neuroimaging, a branch of medical imaging, by providing a window into the living brain. Where CT and conventional MR imaging provide important
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3
More informationERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague
ERN EpiCARE A European Reference Network for Rare and Complex Epilepsies Petr Marusic Motol University Hospital, Prague Disclosure I have no actual or potential conflict of interest in relation to this
More informationNotifiable Medical Conditions
Notifiable Medical Conditions A Acoustic neuroma Addison s disease Agoraphobia AIDS Alcohol problems Alzheimer s disease Amyotrophic Lateral Sclerosis - see Motor Neurone Disease Amputations Aneurysm Angina
More informationOn-line Table 1: Dementia diagnoses and related ICD codes for the diagnostic groups a
On-line Table 1: diagnoses and related ICD codes for the diagnostic groups a Diagnosis (N = 1504) ICD Code Patients Scanned with 3T; SWI (%) Subjective cognitive impairment (n 385) Z03.2A, Z03.3, and R41.8A
More informationEpileptogenesis: A Clinician s Perspective
Epileptogenesis: A Clinician s Perspective Samuel F Berkovic Epilepsy Research Centre, University of Melbourne Austin Health Epileptogenesis The process of development and sustaining the propensity to
More informationI do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
More informationIntroduction to Dementia: Diagnosis & Evaluation. Created in March 2005 Duration: about 15 minutes
Introduction to Dementia: Diagnosis & Evaluation Created in March 2005 Duration: about 15 minutes Axel Juan, MD The Geriatrics Institute axel.juan@med.va.gov 305-575-3388 Credits Principal medical contributor:
More informationThe Ethics of Working with Aging Donors
The Ethics of Working with Aging Donors Tuesday, May 2, 2017 3:30pm Speakers Marla Beck Owner, Andelcare James R. Carney, CFP Morgan Stanley, Financial Advisor Janell Johnson Associate Director of Development:
More informationWhat Happens When Therapy Fails? Therapist Information Sheet
What Happens When Therapy Fails? Therapist Information Sheet Research suggests that most people undertaking therapy have a helpful experience, but sometimes therapy goes wrong. (We use the term therapy
More informationTo Cure Sometimes, To Relieve Often, To Comfort Always
To Cure Sometimes, To Relieve Often, To Comfort Always DDC Clinic mission: To enhance the quality of life for people with special needs caused by rare genetic disorders DDC Clinic Started with a Family
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationCheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy
Cheyenne 11/28 Neurological Disorders II Transmissible Spongiform Encephalopathy -E.g Bovine4 Spongiform Encephalopathy (BSE= mad cow disease), Creutzfeldt-Jakob disease, scrapie (animal only) -Sporadic:
More informationAn approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London
An approach to movement disorders Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London Neurology Diagnosis Two main questions: What parts of the nervous
More information22q11.2 DELETION SYNDROME. Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona)
22q11.2 DELETION SYNDROME Anna Mª Cueto González Clinical Geneticist Programa de Medicina Molecular y Genética Hospital Vall d Hebrón (Barcelona) Genomic disorders GENOMICS DISORDERS refers to those diseases
More informationGenetics of Hereditary Spastic Paraplegia Dr. Arianna Tucci
Genetics of Hereditary Spastic Paraplegia 1 Clinical Research Fellow Institute of Neurology University College London Hereditary spastic paraplegia: definition Clinical designation for neurologic syndromes
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationGenetics of parkinsonian and dystonic syndromes
Genetics of parkinsonian and dystonic syndromes Enza Maria Valente CSS-Mendel Institute, Rome University of Salerno Genetic forms of Parkinson disease 2 polymorphisms (++ in autosomal dominant PD genes:
More informationNeurodegenerative Disease. April 12, Cunningham. Department of Neurosciences
Neurodegenerative Disease April 12, 2017 Cunningham Department of Neurosciences NEURODEGENERATIVE DISEASE Any of a group of hereditary and sporadic conditions characterized by progressive dysfunction,
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationTAKEDA NEUROSCIENCE BRINGING INNOVATIVE MEDICINES TO PATIENTS FOR WHOM THERE ARE NO TREATMENTS AVAILABLE
TAKEDA NEUROSCIENCE BRINGING INNOVATIVE MEDICINES TO PATIENTS FOR WHOM THERE ARE NO TREATMENTS AVAILABLE EMILIANGELO RATTI, PHD Head, Neuroscience Therapeutic Area WE HAVE TAKEN ON THE CHALLENGE TO ALLEVIATE
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_epilepsy 1/28/14 10/2017 10/2018 10/2017 Description of Procedure or Service Description
More information